Literature DB >> 11714805

SH2 domain-containing inositol polyphosphate 5'-phosphatase is the main mediator of the inhibitory action of the mast cell function-associated antigen.

R Xu1, J Abramson, M Fridkin, I Pecht.   

Abstract

The mast cell function-associated Ag (MAFA) is a type II membrane glycoprotein originally found on the plasma membrane of rat mucosal-type mast cells (RBL-2H3 line). A C-type lectin domain and an immunoreceptor tyrosine-based inhibitory motif (ITIM) are located in the extracellular and intracellular domains of MAFA, respectively. MAFA clustering has previously been shown to suppress the secretory response of these cells to the FcepsilonRI stimulus. Here we show that the tyrosine of the ITIM undergoes phosphorylation, on MAFA clustering, that is markedly enhanced on pervanadate treatment of the cells. Furthermore, the Src homology 3 domain of the protein tyrosine kinase Lyn binds directly to a peptide containing nonphosphorylated MAFA ITIM and PAAP motif. Results of both in vitro and in vivo experiments suggest that Lyn is probably responsible for this ITIM phosphorylation, which increases the Src homology domain 2 (SH2) affinity of Lyn for the peptide. In vitro measurements established that tyrosine-phosphorylated MAFA ITIM peptides also bind the SH2 domains of inositol 5'-phosphatase (SHIP) as well as protein tyrosine phosphatase-2. However, the former single domain is bound 8-fold stronger than both of the latter. Further support for the role of SHIP in the action of MAFA stems from in vivo experiments in which tyrosine-phosphorylated MAFA was found to bind primarily SHIP. In RBL-2H3 cells overexpressing wild-type SHIP, MAFA clustering causes markedly stronger inhibition of the secretory response than in control cells expressing normal SHIP levels or cells overexpressing either wild-type protein tyrosine phosphatase-2 or its dominant negative form. In contrast, on overexpression of the SH2 domain of SHIP, the inhibitory action of MAFA is essentially abolished. Taken together, these results suggest that SHIP is the primary enzyme responsible for mediating the inhibition by MAFA of RBL-2H3 cell response to the FcepsilonRI stimulus.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11714805     DOI: 10.4049/jimmunol.167.11.6394

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  11 in total

Review 1.  KLRG1--more than a marker for T cell senescence.

Authors:  Sian M Henson; Arne N Akbar
Journal:  Age (Dordr)       Date:  2009-12

2.  Immunoregulatory functions of KLRG1 cadherin interactions are dependent on forward and reverse signaling.

Authors:  Cindy Banh; Céline Fugère; Laurent Brossay
Journal:  Blood       Date:  2009-10-23       Impact factor: 22.113

3.  The inositol 5-phosphatase SHIP-1 and adaptors Dok-1 and 2 play central roles in CD4-mediated inhibitory signaling.

Authors:  Paul M Waterman; Susanne Marschner; Erin Brandl; John C Cambier
Journal:  Immunol Lett       Date:  2012-02-24       Impact factor: 3.685

4.  An immunoglobulin-like receptor, Allergin-1, inhibits immunoglobulin E-mediated immediate hypersensitivity reactions.

Authors:  Kaori Hitomi; Satoko Tahara-Hanaoka; Satoru Someya; Akira Fujiki; Hideaki Tada; Tetsuya Sugiyama; Shiro Shibayama; Kazuko Shibuya; Akira Shibuya
Journal:  Nat Immunol       Date:  2010-06-06       Impact factor: 25.606

Review 5.  Inhibitor and activator: dual functions for SHIP in immunity and cancer.

Authors:  William G Kerr
Journal:  Ann N Y Acad Sci       Date:  2010-12-13       Impact factor: 5.691

6.  Selective inhibition of the Fc epsilon RI-induced de novo synthesis of mediators by an inhibitory receptor.

Authors:  Jakub Abramson; Arieh Licht; Israel Pecht
Journal:  EMBO J       Date:  2006-01-12       Impact factor: 11.598

Review 7.  The multiple roles of phosphoinositide 3-kinase in mast cell biology.

Authors:  Mi-Sun Kim; Madeleine Rådinger; Alasdair M Gilfillan
Journal:  Trends Immunol       Date:  2008-09-03       Impact factor: 16.687

Review 8.  Inhibitory C-type lectin receptors in myeloid cells.

Authors:  Pierre Redelinghuys; Gordon D Brown
Journal:  Immunol Lett       Date:  2010-10-08       Impact factor: 3.685

9.  Functions and clinical significance of KLRG1 in the development of lung adenocarcinoma and immunotherapy.

Authors:  Xiaodong Yang; Yuexin Zheng; Zhihai Han; Xiliang Zhang
Journal:  BMC Cancer       Date:  2021-06-29       Impact factor: 4.430

Review 10.  CD155 immunoregulation as a target for natural killer cell immunotherapy in glioblastoma.

Authors:  Kyle B Lupo; Sandro Matosevic
Journal:  J Hematol Oncol       Date:  2020-06-12       Impact factor: 17.388

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.